Can I reuse my CE file for Saudi Arabia (SFDA)?

In short: Yes, to a large degree: SFDA's technical framework closely mirrors EU MDR, so much of a CE technical file transfers directly to an MDMA application. Since January 2022 SFDA has required a complete technical file for every registration (set out in its MDS-REQ 1 requirements document) — and a CE mark still carries formal recognition weight in the review. A CE-shaped file is the strongest starting point.

Why the overlap is unusually good here

Saudi Arabia's medical device regulator, SFDA, built its Medical Device Marketing Authorization (MDMA) framework with deliberate structural similarity to EU MDR — closer, in practice, than the relationship between MDR and FDA's submission logic. Device classification, the general safety and performance requirement structure, and the expected technical documentation sections in an SFDA submission map closely enough to an MDR technical file that a well-built CE dossier is genuinely the strongest starting point for an MDMA application, not just a helpful reference.

What SFDA actually requires — and what your CE mark is still worth

Since 1 January 2022, SFDA has required a complete, self-contained technical file for every registration — the requirement is set out in its MDS-REQ 1 requirements document (Requirements for Medical Devices Marketing Authorization, version 6, published December 2021), and it closed an earlier route that had accepted CE or FDA determinations more directly as a basis for registration. But that tightening removed a shortcut, not the CE mark's standing: the MDMA pathway still leverages prior approval from recognised reference regulators — the GHTF founding jurisdictions (EU, US, Canada, Australia, and Japan) — so a CE mark carries real formal recognition weight in a Saudi submission. SFDA still makes its own determination; expect to submit the full file, even if most of its content is drawn directly from your CE dossier.

What still needs local adaptation

Even with strong structural overlap, an MDMA submission needs its own cover documentation, needs to be submitted through your appointed in-country Authorised Representative — itself an establishment licensed by SFDA — and needs any labeling or language requirements specific to the Saudi market addressed directly rather than assumed to carry over from your EU documentation. Re-confirm your device classification under SFDA's rules too: it usually mirrors MDR, but that isn't guaranteed. Treat the CE file as your evidence base and starting structure, not a document you resubmit unchanged — plan for adaptation, not just translation.

Where next: SFDA Medical Device Registration (MDMA) · Do I need an in-country representative in Saudi Arabia?

Talk to us about your SFDA registration strategy. Book an expert conversation →